
Oncology NEWS International
- Oncology NEWS International Vol 5 No 11
- Volume 5
- Issue 11
FDA Approves Xillix LIFE-Lung System
ROCKVILLE, Md-The FDA has given final approval to the Xillix LIFE-Lung Fluorescence Endoscopy System for use in detecting early lung cancer. Xillix Technologies Corp., of Richmond, British Columbia, plans to market the system worldwide in early 1997.
ROCKVILLE, MdThe FDA has given final approval to the Xillix LIFE-Lung Fluorescence Endoscopy System for use in detecting early lung cancer. Xillix Technologies Corp., of Richmond, British Columbia, plans to market the system worldwide in early 1997.
Articles in this issue
about 29 years ago
Factor Analysis of New Symptom Scale in Breast Cancer Finds Six Clustersabout 29 years ago
AIDS Funding Increased for Fiscal '97about 29 years ago
'Cancer Rates and Risks' Availableabout 29 years ago
New Breast Cancer Patient Resource Is Availableabout 29 years ago
Short-Term Metronidazole not Linked to Cancerabout 29 years ago
Various Capitation Models Are Available for Oncology Networksabout 29 years ago
NCI Urges full Disclosure of Cigarette Contentsabout 29 years ago
Antifungal Resistance on the Increaseabout 29 years ago
Fentanyl Patch Useful Alternative in Cancer Pain Patientsabout 29 years ago
Analysis of Microvessel Density Predicts Extraprostatic SpreadNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.















































































